Close Menu
Business Voice NowBusiness Voice Now
    Facebook X (Twitter) Instagram
    Business Voice NowBusiness Voice Now
    Subscribe
    • Markets
      • BFSI
      • Capital Goods
    • Business
      • FMCG
      • Retail
      • Quick Commerce
      • Startups
    • Healthcare
    • Technology
    • Energy
    • Voices
      • Entrepreneur – CXO Stories
      • Corporate Office story
    • E Magazine
      • Year 2026
        • August 2026
        • July 2026
    Business Voice NowBusiness Voice Now
    Home»Health»Renowned Cardiologist Dr Luca Testa Highlights the Effectiveness of Abluminus DES+ in Complex Angioplasty Cases
    Health

    Renowned Cardiologist Dr Luca Testa Highlights the Effectiveness of Abluminus DES+ in Complex Angioplasty Cases

    By July 10, 2023No Comments3 Mins Read
    Share Facebook Twitter Pinterest LinkedIn Tumblr Email
    Follow Us
    Google News Flipboard Threads
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Faridabad/Aligarh [India], July 10: Dr Luca Testa, a renowned interventional cardiologist at IRCCS Policlinico San Donato – Milan, Italy, has successfully conducted a series of educational workshops on the effectiveness of Abluminus DES+ in complex percutaneous coronary intervention. These workshops, organized by Concept Medical as part of their educational initiative, showcased the superior capabilities of Abluminus DES+ in treating complex lesions and diffuse disease in angioplasty.

    The first workshop was held on 3rd July 2023 at Jawaharlal Nehru Medical College and Hospital (Aligarh Muslim University) in collaboration with Dr Asif Hasan and Dr Azharuddin Malik. The second workshop took place on 4th July 2023 at Fortis Escorts Hospital, Faridabad, with the participation of Dr Sanjay Kumar alongside Dr. Luca Testa.

    Dr. Luca Testa expressed his satisfaction with the outcomes achieved using Abluminus DES+ in all the workshops conducted in various Indian institutions. The cases involved patients with complex coronary disease, including chronic total occlusions (CTOs) and severe in-stent restenosis.

    “Abluminus DES+ has been my choice of stent for many years, particularly in complex cases, and the results have been promising,” stated Dr. Luca Testa during a press conference. “This unique combination of a drug-coated balloon and a bioresorbable polymer sirolimus-eluting stent offers distinct advantages, especially when treating complex and diffuse disease. It is noteworthy that interventional cardiology is undergoing a significant paradigm shift. Despite the availability of advanced DES technologies like Abluminus DES+, we are progressively changing our approach, considering alternative options such as the Sirolimus-coated balloon Magic Touch. I firmly believe that in the future, we will witness a further implementation of drug-coated balloon technology in our daily practice, either alongside or even independently of stent usage. Abluminus is undoubtedly one of the finest technologies available, especially for complex cases.”

    Dr. Luca Testa’s workshops have provided valuable insights into the efficacy and potential of Abluminus DES+ in complex angioplasty procedures. With these educational initiatives, Concept Medical and Dr Testa aim to enhance the knowledge and expertise of healthcare professionals in India, ultimately leading to improved patient outcomes and advancing the field of interventional cardiology.

    Explaining the innovation, Concept Medical’s Founder & MD, Dr Manish Doshi, said, “In several patients with type II diabetes and coronary heart disease, there is as recurrence of major adverse cardiac events (MACE) like heart attack, stroke and restenosis (narrowing of unblocked artery after operation). This abluminal drug-eluting stent DES+ will considerably reduce the chances of recurrence.”

    About Dr. Luca Testa:

    Dr. Luca Testa is a renowned interventional cardiologist at IRCCS Policlinico San Donato – Milan, Italy. With extensive experience in complex coronary interventions, Dr. Testa has been instrumental in the development and advancement of novel treatment options in the field of interventional cardiology.

    If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

    Health
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

    Related Posts

    Bharuch Gets 24×7 Neuro and Spine Super-Speciality Hospital with Advanced Robotic Rehabilitation Facilities

    August 20, 2026

    New Suction Technology Is Changing How Kidney Stones Are Removed Without Open Surgery

    August 19, 2026

    Periodontal Specialist Dr. Vinitha Ramachandran Highlights the Critical Link Between Diabetes and Oral Health

    August 12, 2026

    Comments are closed.

    Recent Post
    • UMC Hospitals, Nashik to Commence Patient Services from September 1, 2026
    • This Raksha Bandhan, Gift Your Sibling More Space for What They Love with Kingston Technology
    • Groweon Evolves CRM into a ‘System of Action’ with AION Agentic AI
    • Waterways Leisure Tourism Shares Turn Ex-Split Today; 1:10 Stock Split Takes Effect
    • Blue Cloud Softech Board Approves In-Principle Proposal to Acquire US-Based CareTech AI
    • Rohit Sharma joins LightFury Games as Investor Alongside MS Dhoni, Jasprit Bumrah and Hardik Pandya; eCricket Closed Beta Begins September 2026
    • AIChE Student Regional Conference ‘Viplav SRC 2026’ Concludes Successfully at RGIPT
    • Rocket Reels Celebrates 1-Year Anniversary With Star-Studded Success Party and Kranti Shanbhag’s Birthday

    Type above and press Enter to search. Press Esc to cancel.